Navigation Links
Europe spends nearly twice as much as US on nanotech risk research
Date:4/21/2008

Washington, DC A new analysis by the Project on Emerging Nanotechnologies (PEN) indicates that European nations are investing nearly twice as much as the U.S. in research primarily aimed at addressing the potential risks of nanotechnology. The analysis also highlights a substantial over-inflation of the federal governments nanotechnology risk-research investment figures for the U.S.

The new PEN assessment of nanotechnology risk-relevant projects identified by the federal governments National Nanotechnology Initiative (NNI) for fiscal year 2006 found that only $13 million was invested in projects highly relevant to addressing possible risks.

Over the same time period, the PEN analysis found European countries invested nearly $24 million in projects with the primary aim of addressing nanotechnology risks.

PEN evaluated research projects listed in the NNI research strategyreleased in February 2008 but without specifics regarding the annual project budget or the applicability of each project to assessing potential hazardsby their relevance to addressing current and future nanotechnology risks. Research was classified according to whether it was highly relevant to addressing potential environment, health or safety hazards, substantially relevant, having some relevance, or was only marginally relevant.

By collecting individual project budget data from publicly available sources, an estimate was made of funding levels for 2006. The assessment found 62 federally-funded projects that were highly relevant to understanding nanotechnology risk, with an estimated annual budget of $13 million.

In contrast, the federal government estimates $37.7 million was invested in highly relevant research in fiscal year 2006. According to PEN Chief Science Advisor Andrew Maynard, It appears the U.S. is guilty of wishful thinking in its assessment of research that will lead to the development of safe nanotechnologies. It is trying to sub
'/>"/>

Contact: Julia Moore
julia.moore@wilsoncenter.org
202-691-4025
Project on Emerging Nanotechnologies
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
2. Squire Sanders Stands Out in Independent Analysis of Law Firms in Europe
3. High-Definition Technology to Revolutionize US & European Visualization Device Markets
4. Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)
5. Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
6. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
7. MaxCyte to Present at BIO-Europe Spring 2008 Conference
8. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
9. Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
10. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
11. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 Dendreon Corporation (Nasdaq: DNDN ... public offering of 15,000,000 shares of its common stock ... share. Dendreon also granted to the underwriters a ... shares of common stock to cover overallotments, if any. ... 15, 2009, subject to customary closing conditions. ,, J. ...
(Date:12/10/2009)... a division of the National Institutes of Health (NIH), awarded ... its development of a non-invasive, passive diffusion-based treatment for severe, ... ... Salt Lake City, UT (PRWEB) December 10, 2009 -- The ... of Health (NIH), awarded a $2.18 million grant to Aciont ...
(Date:12/10/2009)... YM BioSciences Inc. (NYSE Amex: YMI ; ... that identifies and advances a diverse portfolio of ... today provided an update on the proposed transaction ... Ltd. into YM, details of which were announced ... of Cytopia has unanimously recommended that its shareholders ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... FORD, Pa., Jan. 28 Endo Pharmaceuticals Inc. (Nasdaq: ... and 2008 full-year financial results on February 27, 2009 ... at 10:30 a.m. ET that day to discuss these ... Officer, Nancy J. Wysenski, Chief Operating Officer and Blaine ...
... Today the Swiss,pharmaceutical group Helsinn announced the ... with headquarters in,Bridgewater, New Jersey, for an undisclosed ... of a US-based R&D and commercial operation represents,attainment ... goals. "We are,thrilled at this very important opportunity ...
... NOVATO, Calif., Jan. 28 BioMarin Pharmaceutical,Inc. (Nasdaq: ... BioMarin, will host a conference call and webcast on,Wednesday, February ... quarter,and full year 2008 financial results. , , ... International Dial-in Number: 617.213.8835, Participant ...
Other Biology Technology:Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 3BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET) 2
(Date:12/14/2009)... researchers from the Astrobiology Centre (INTA-CSIC) has shown that ... the formation of the most basic biological molecules can ... to carry out this study, published in the journal ... chemical conditions of the early Earth. , "We have ... solutions it produces hydrogen cyanide, a substance that could ...
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
(Date:12/13/2009)... variants that are associated with the health of the ... 96 scientists from 63 centres in Europe and Australia ... diseases. , The new findings provide hope for better ... (COPD) and asthma. In the past it has been ... that affect the health of the lung are not ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 1iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 3
... A rat thought extinct for 11 million years and a ... discovered in the Greater Mekong Region of Southeast Asia in ... World Wildlife Fund (WWF). , First Contact in ... newly identified by science between 1997 and 2007 which ...
... 15, 2008) A newly published genome sequence of ... rearranged genetic blueprint involving breaks and fusions of genes ... Baylor College of Medicine in a report that appears ... "It,s like a computer program that has become buggy ...
... study uncovers 11 gene variants associated with three ... low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) and ... nutrigenomics researchers looking for links between diet and ... disease risk. , "Practically all genes related to ...
Other Biology News:Over 1,000 species discovered in the Greater Mekong in past decade 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3New gene variants present opportunities in nutrigenomics 2
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
Complexin-1/2 (FL-134)...
RAW; Collected from 8-12 week old sexually mature mice that are free of common parasites; RAW Collected from 8-12 week old sexually mature mice that are free of common parasites....
Biology Products: